Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

G Jia, VG DeMarco, JR Sowers - Nature Reviews Endocrinology, 2016 - nature.com
Insulin resistance, type 2 diabetes mellitus and associated hyperinsulinaemia can promote
the development of a specific form of cardiomyopathy that is independent of coronary artery …

Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy

TH Marwick, R Ritchie, JE Shaw, D Kaye - Journal of the American College …, 2018 - jacc.org
Heart failure is a complex clinical syndrome, the incidence and prevalence of which is
increased in diabetes mellitus, pre-diabetes, and obesity. Although this may arise from …

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

J Habibi, AR Aroor, JR Sowers, G Jia… - Cardiovascular …, 2017 - Springer
Obese and diabetic individuals are at increased risk for impairments in diastolic relaxation
and heart failure with preserved ejection fraction. The impairments in diastolic relaxation are …

Type 2 diabetes mellitus and hypertension: an update

G Lastra, S Syed, LR Kurukulasuriya… - Endocrinology and …, 2014 - endo.theclinics.com
Hypertension (HTN) is present in more than 50% of patients with diabetes mellitus (DM) and
contributes significantly to both microvascular and macrovascular disease in DM (Fig. 1). 1 …

[HTML][HTML] Diabetic cardiomyopathy: where we are and where we are going

WS Lee, J Kim - The Korean journal of internal medicine, 2017 - ncbi.nlm.nih.gov
The global burden of diabetes mellitus and its related complications are currently increasing.
Diabetes mellitus affects the heart through various mechanisms including microvascular …

Three generations of β-blockers: history, class differences and clinical applicability

GT do Vale, CS Ceron, NA Gonzaga… - Current hypertension …, 2019 - ingentaconnect.com
Background: Beta-adrenergic receptors are expressed in cardiomyocytes and activated by
either noradrenaline released from sympathetic synapses or circulating catecholamines …

Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease

J Ren, L Pulakat, A Whaley-Connell… - Journal of molecular …, 2010 - Springer
The metabolic syndrome is a constellation of metabolic disorders including obesity,
hypertension, and insulin resistance, components which are risk factors for the development …

Diabetes mellitus and vascular disease

JR Sowers - Hypertension, 2013 - Am Heart Assoc
944 Hypertension May 2013 bioavailable nitric oxide. 15–19 The decreased bioavailability
of nitric oxide reduces endothelial-mediated vascular relaxation and promotes vascular …

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes

CH Mandavia, AR Aroor, VG DeMarco, JR Sowers - Life sciences, 2013 - Elsevier
Diabetes mellitus type 2 (T2DM) is a widespread chronic medical condition with prevalence
bordering on the verge of an epidemic. It is of great concern that cardiovascular disease is …

Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo

C Zeng, P Zhong, Y Zhao, K Kanchana, Y Zhang… - Journal of molecular and …, 2015 - Elsevier
Obesity and increased free fatty acid (FFA) level are tightly linked, leading to the
development of cardiovascular disorders. Curcumin is a natural product from Curcuma …